Cristina Legido-Quigley
banner
legidoquigley.bsky.social
Cristina Legido-Quigley
@legidoquigley.bsky.social
Scientist doing clinical research, studies 1000s molecules “omics” in brain 🧠 & Liver disease, Dementia & Diabetes
Technology massspec, lipidomics & metabolomics, proteins & 🧬 big data
hobbies 🌱 & 🎨
Reposted by Cristina Legido-Quigley
Reposted by Cristina Legido-Quigley
Stoked to see this essay on the involvement of the white matter in Alzheimer’s disease published and Constanze Depp being one of the finalists for the Eppendorf & Science Prize for Neurobiology this year! 🎉

www.science.org/doi/10.1126/...
White matters arising: Rethinking Alzheimer’s disease through the lens of myelin
Rethinking Alzheimer’s disease through the lens of myelin
www.science.org
October 31, 2025 at 7:00 AM
My first meal in Korea "hangover soup" it is hearty & spicy, & full of bones, what I need after 24h transit from kings in London to seoul
October 28, 2025 at 4:37 PM
Reposted by Cristina Legido-Quigley
Resources:
@femalesinms.bsky.social Underrepresented Scientists Directory: femalesinms.com/underreprese...
@legidoquigley.bsky.social List of women in metabolomics, lipidomics, proteomics & related data science: docs.google.com/document/d/1...
Underrepresented Scientists Directory
The FeMS+ directory of underrepresented scientists is a resource for conferences, professional societies and journals in mass spectrometry and related fields to build diverse and inclusive panels o…
femalesinms.com
October 27, 2025 at 10:45 PM
Reposted by Cristina Legido-Quigley
To be honest, when I see conferences announced that have a majority of male invited speakers, I think the organisers are not trying hard enough. We have so many excellent #FemalesinMS and resources available there is really no excuse for it anymore #massspec #teammassspec #lipidomics #metabolomics
October 27, 2025 at 10:45 PM
Reposted by Cristina Legido-Quigley
Another potential health breakthrough.
Galleri test: Exciting results from blood test for 50 cancers
The Galleri test looks for fragments of DNA that have broken off a tumour and are circulating in the blood.
www.bbc.com
October 18, 2025 at 8:42 AM
Napping option number 2: the perfect circle
#catsofsky #caturday
October 18, 2025 at 9:40 AM
Reposted by Cristina Legido-Quigley
📣 Excited to share that my first paper is now published!

📄"Metabolic state shapes cortisol reactivity to acute stress: A systematic review and meta-analysis of metabolic and hormonal modulators"

You can find the full paper here:
doi.org/10.1016/j.yn...
Redirecting
doi.org
October 15, 2025 at 11:27 AM
Reposted by Cristina Legido-Quigley
Last year, I had a paper rejected after 18 months with the @amjepi.bsky.social.

It's the first time I've had a paper rejected after being invited for revisions. And the first time I've had a paper sent out to completely new reviewers.

It stung so hard that it's taken me a year to look at again.
Every academic career is built on rejection, but we don’t show it.

CVs list publications, grants & awards, not rejected manuscripts, unfunded proposals, or failures.

But those invisible rejections shape us more than our successes ever do.

👉 catherineeunicedevries.substack.com/p/fail-bette...

🧵
Fail Better: Why Your Rejections Will Shape You More Than Your Publications
The Art of Learning from Rejection
catherineeunicedevries.substack.com
October 14, 2025 at 11:26 AM
what is the name of this tree or bush in Hyde Park in London? #gardening 🌿🍂 #fall
October 11, 2025 at 3:44 PM
A week in our home, looking like she planned the whole move herself #caturday #catsofsky
October 11, 2025 at 10:05 AM
🤓 saturated fatty acids are also neuron friendly www.nature.com/articles/s42...
www.nature.com
October 6, 2025 at 7:10 AM
We got given this cat by a lovely lady, two days in she's chilled #caturday #catsofsky
October 4, 2025 at 12:15 PM
Reposted by Cristina Legido-Quigley
📣The 2026 ERC Consolidator Grant competition is now open! 📣

Already preparing your proposal? Info links ⬇️

Info for applicants 👉 buff.ly/PSbeUxX

Application portal 👉 buff.ly/mauZoqo

Deadline: 13/01/26

General info on #ERCCoG 👉 buff.ly/KCN6GTh
September 26, 2025 at 2:30 PM
Reposted by Cristina Legido-Quigley
Hace casi dos décadas que Pasqual Maragall anunció que padecía alzhéimer. En una entrevista con EL PAÍS, su hija, Cristina Maragall, habla sobre su padre, pero también desmenuza la revolución científica del alzhéimer y las carencias de los cuidadores de estas personas
elpais.com/salud-y-bien...
Cristina Maragall: “A la Administración pública le ha ido muy bien que las mujeres se hicieran cargo de los enfermos de alzhéimer”
La presidenta de la Fundación Pasqual Maragall explica que su padre, el exalcalde de Barcelona diagnosticado hace 18 años de la enfermedad, “está muy tranquilo y sigue una vida muy rutinaria”
elpais.com
September 21, 2025 at 6:45 AM
Very happy to share this article which came out today 💜#WorldAlzheimersDay in @telegraphnews.bsky.social
The health editor wrote a fantastic article focusing in women that includes our recent work, & a lot of prevention strategies
access to the article in the link & via email in the comments
September 21, 2025 at 4:21 PM
Reposted by Cristina Legido-Quigley
Research Highlight by @drarunimasingh.bsky.social: Spatiotemporal lipidomics in living tissue

www.nature.com/articles/s41...
Spatiotemporal lipidomics in living tissue - Nature Methods
Nature Methods - Spatiotemporal lipidomics in living tissue
www.nature.com
September 11, 2025 at 4:44 PM
Reposted by Cristina Legido-Quigley
Peer reviewers are exhausted. It's common to spend *months* inviting reviewers, getting refusals, inviting more, maybe 12 or more, then 2 agree but 1 doesn't complete, so you go again. That's why your paper is in limbo. I'm very sorry, it's awful, but it's also an untenable academic labour issue.
September 6, 2025 at 11:22 PM
Reposted by Cristina Legido-Quigley
People with #MASLD can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 #diabetes, #cardiovascular disease, chronic #kidney disease, and extrahepatic #cancers www.thelancet.com/journals/lan...
#T2D #CVD #CKD
#OpenAccess

#MedSky #EndoSky #LiverSky
September 6, 2025 at 10:51 AM
Reposted by Cristina Legido-Quigley
If you're a woman, please make sure to eat more unsaturated fats, especially omega-3s, than saturated fats.

A cheap way to get omega-3s is to eat canned sardines. 🐟

#WomenHealth #wellbeing #wellness #brainhealth #Alzheimer #omega3
Levels of Omega-3 Could Help Explain Women's Alzheimer's Risk
There's something about the female brain that makes it more susceptible to Alzheimer's disease.
www.sciencealert.com
September 1, 2025 at 6:33 PM
Reposted by Cristina Legido-Quigley
Along with this: it's tempting to collect technical skills like pokemon, and there certainly is focus on work with breadth that rewards this. But don't forget about the value of depth. Hard to do good science without deep understanding of what you're doing. That only comes from years of immersion.
Same with bioinformatics, honestly. Doing a two-month rotation in a lab that uses computation is going to give you a taste, but don't fool yourself into thinking you'll develop meaningful transferrable skill in that time
September 1, 2025 at 8:52 PM
Reposted by Cristina Legido-Quigley
(ABioanChem) Global metabolomics profiling of glucuronides in human plasma, fecal, and cerebrospinal fluid samples: Glucuronidation is the major phase II biotransformation reaction that facilitates the clearance of exogenous compounds from the human body. Glucuronidated metabolites… #MassSpecRSS
Global metabolomics profiling of glucuronides in human plasma, fecal, and cerebrospinal fluid samples
Glucuronidation is the major phase II biotransformation reaction that facilitates the clearance of exogenous compounds from the human body. Glucuronidated metabolites have been investigated in urine samples at a broad scale; however, their characterization in other human biospecimens is underexplored. Our study has now performed a comprehensive profiling of glucuronides in plasma, fecal, and cerebrospinal fluid (CSF) of humans. We performed a mass spectrometry-based analysis that combines enzymatic hydrolysis with a β-glucuronidase to selectively cleave the glucuronic acid moiety, a developed in-house glucuronide identification pipeline, and enzymatic synthesis of standard metabolites. In total, we identified 32 glucuronidated metabolites across the three sample types in both negative and positive mass spectrometry ionization modes using advanced MS/MS fragmentation analysis. We have utilized a straightforward enzymatic synthesis of glucuronidated metabolites for annotation at the highest confidence level. Among the identified conjugates, we detected glucuronides of different compound classes including drugs, bile acid derivatives, steroid conjugates, and phenolic compounds. Unexpectedly, we validated the glucuronides of acetaminophen and propofol in CSF samples, the latter representing a novel observation that highlights the importance of investigating phase II metabolites in uncommon sample types. Graphical Abstract
dlvr.it
September 1, 2025 at 9:05 PM
Reposted by Cristina Legido-Quigley
Imaging myelin degradation in ex vivo prefrontal cortex tissue blocks in Alzheimer's disease and chronic traumatic encephalopathy

alz-journals.onlinelibrary.wiley.com/doi/full/10....
Imaging myelin degradation in ex vivo prefrontal cortex tissue blocks in Alzheimer's disease and chronic traumatic encephalopathy
INTRODUCTION Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE) are tauopathies with gray matter (GM) myelin changes that are challenging to assess with standard imaging. New method...
alz-journals.onlinelibrary.wiley.com
August 25, 2025 at 6:14 AM